MedTrace Logo

Circulating Markers for Ischemic Heart Disease

NCT00762333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2025-08-12

No results posted yet for this study

Summary

The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.

Conditions

Sponsors & Collaborators

  • UConn Health

    lead OTHER

Principal Investigators

  • Bruce T. Liang, MD · UConn Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762333 on ClinicalTrials.gov